O. Kalid

发表

Genomic and molecular characterization of esophageal squamous cell carcinoma

Li Shang, Xin Xu, Henry Yang, 2014, Nature Genetics.

PREDICT modeling and in‐silico screening for G‐protein coupled receptors

Maya Topf, Shay Bar-Haim, Yael Marantz, 2004, Proteins.

Conserved interactions required for in vitro inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

E. Segev, Idit Buch, E. Ben-Zeev, 2020, bioRxiv.

Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

E. Segev, Idit Buch, E. Ben-Zeev, 2020, Scientific Reports.

5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.

G. Reiser, B. Fischer, Tamar Ginsburg-Shmuel, 2010, Journal of Medicinal Chemistry.

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

A. Rosato, P. Carloni, E. Baloglu, 2017, Nature Communications.

Selinexor-Induced Thrombocytopenia Results from the Inhibition of Megakaryocyte Progenitor Cells in the Early Stage of Megakaryopoiesis

R. Carlson, J. Italiano, K. Machlus, 2014 .

Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors

Woody Sherman, Ori Kalid, Dora Toledo Warshaviak, 2012, Journal of Computer-Aided Molecular Design.

Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds

B. Klebanov, W. Senapedis, Y. Landesman, 2015, BMC Cancer.

Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands

Kai Zhu, Kenneth W. Borrelli, Ori Kalid, 2014, J. Chem. Inf. Model..

Study of MDM2 Binding to p53-Analogues: Affinity, Helicity, and Applicability to Drug Design

Nir Ben-Tal, Ori Kalid, N. Ben-Tal, 2009, J. Chem. Inf. Model..

PTX80, a novel compound targeting the autophagy receptor p62/SQSTM1 for treatment of cancer

O. Kalid, Etai Rotem, Einat Levy-Apter, 2022, Chemical biology & drug design.

G protein-coupled receptors: in silico drug discovery in 3D.

Shay Bar-Haim, Yael Marantz, Alexander Heifetz, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator*

Hanoch Senderowitz, Julie D. Forman-Kay, Efrat Noy, 2012, The Journal of Biological Chemistry.

New Model of Cystic Fibrosis Transmembrane Conductance Regulator Proposes Active Channel-like Conformation

Jordi Villà-Freixa, Nir Ben-Tal, Maya Schushan, 2012, J. Chem. Inf. Model..

Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening

Efrat Ben-Zeev, Martin Mense, Ori Kalid, 2010, J. Comput. Aided Mol. Des..

Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds

B. Klebanov, W. Senapedis, Y. Landesman, 2015, BMC Cancer.

G protein coupled receptors -in silico drug discovery and design.

H. Senderowitz, M. Strajbl, E. Ben-Zeev, 2010, Current topics in medicinal chemistry.

Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator*

H. Senderowitz, R. Vernon, Inbal Sela-Culang, 2012, The Journal of Biological Chemistry.